Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia

被引:416
作者
Ang, SO
Chen, H
Hirota, K
Gordeuk, VR
Jelinek, J
Guan, YL
Liu, EL
Sergueeva, AI
Miasnikova, GY
Mole, D
Maxwell, PH
Stockton, DW
Semenza, GL
Prchal, JT [1 ]
机构
[1] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[2] Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL USA
[3] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA
[4] Howard Univ, Dept Med, Washington, DC 20059 USA
[5] Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA
[6] Chuvash State Univ, Cheboksary, Chuvashia, Russia
[7] Univ Oxford, Oxford, England
[8] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
关键词
D O I
10.1038/ng1019
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Chuvash polycythemia is an autosomal recessive disorder that is endemic to the mid-Volga River region. We previously mapped the locus associated with Chuvash polycythemia to chromosome 3p25. The gene associated with von Hippel-Lindau syndrome, VHL, maps to this region, and homozygosity with respect to a C-->T missense mutation in VHL, causing an arginine-to-tryptophan change at amino-acid residue 200 (Arg200Trp), was identified in all individuals affected with Chuvash polycythemia. The protein VHL modulates the ubiquitination and subsequent destruction of hypoxia-inducible factor 1, subunit alpha(HIF1alpha). Our data indicate that the Arg200Trp substitution impairs the interaction of VHL with HIF1alpha reducing the rate of degradation of HIF1alpha and resulting in increased expression of downstream target genes including EPO (encoding erythropoietin), SLC2A1 (also known as GLUT1, encoding solute carrier family 2 (facilitated glucose transporter), member 1), TF (encoding transferrin), TFRC (encoding transferrin receptor (p90, CD71)) and VEGF (encoding vascular endothelial growth factor).
引用
收藏
页码:614 / 621
页数:8
相关论文
共 34 条
[1]   Endemic polycythemia in Russia: Mutation in the VHL gene [J].
Ang, SO ;
Chen, H ;
Gordeuk, VR ;
Sergueeva, AI ;
Polyakova, LA ;
Miasnikova, GY ;
Kralovics, R ;
Stockton, DW ;
Prchal, JT .
BLOOD CELLS MOLECULES AND DISEASES, 2002, 28 (01) :57-62
[2]   Software and database for the analysis of mutations in the VHL gene [J].
Béroud, C ;
Joly, D ;
Gallou, C ;
Staroz, F ;
Orfanelli, MT ;
Junien, C .
NUCLEIC ACIDS RESEARCH, 1998, 26 (01) :256-258
[3]  
Beutler E., 1971, Red Cell Metabolism
[4]   Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease [J].
Clifford, SC ;
Cockman, ME ;
Smallwood, AC ;
Mole, DR ;
Woodward, ER ;
Maxwell, PH ;
Ratcliffe, PJ ;
Maher, ER .
HUMAN MOLECULAR GENETICS, 2001, 10 (10) :1029-1038
[5]   C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation [J].
Epstein, ACR ;
Gleadle, JM ;
McNeill, LA ;
Hewitson, KS ;
O'Rourke, J ;
Mole, DR ;
Mukherji, M ;
Metzen, E ;
Wilson, MI ;
Dhanda, A ;
Tian, YM ;
Masson, N ;
Hamilton, DL ;
Jaakkola, P ;
Barstead, R ;
Hodgkin, J ;
Maxwell, PH ;
Pugh, CW ;
Schofield, CJ ;
Ratcliffe, PJ .
CELL, 2001, 107 (01) :43-54
[6]  
Gordeuk VR, 2001, BLOOD, V98, p224A
[7]   Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor [J].
Haase, VH ;
Glickman, JN ;
Socolovsky, M ;
Jaenisch, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) :1583-1588
[8]  
HAGESAWA K, 1990, BIOCHIM BIOPHYS ACTA, V1051, P221
[9]   Structural basis for the recognition of hydroxyproline in αIF-1α by pVHL [J].
Hon, WC ;
Wilson, MI ;
Harlos, K ;
Claridge, TDW ;
Schofield, CJ ;
Pugh, CW ;
Maxwell, PH ;
Ratcliffe, PJ ;
Stuart, DI ;
Jones, EY .
NATURE, 2002, 417 (6892) :975-978
[10]   HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing [J].
Ivan, M ;
Kondo, K ;
Yang, HF ;
Kim, W ;
Valiando, J ;
Ohh, M ;
Salic, A ;
Asara, JM ;
Lane, WS ;
Kaelin, WG .
SCIENCE, 2001, 292 (5516) :464-468